FDA Inspection 732180 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 3006604254

The FDA completed an inspection of Octapharma Plasma Inc on June 7, 2011 in Omaha, NE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 7, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Omaha, NE (United States)

Citations

IDCFRDescription
9821 CFR 606.100(c)Thorough investigations